Ads
related to: mylan nasdaq
Search results
Viatris' Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates
Benzinga via Yahoo Finance· 2 years agoViatris Inc's (NASDAQ: VTRS) Mylan is voluntarily recalling one lot of Octreotide Acetate Injection,...
US Supreme Court Turns Away Biogen's Last Effort To Reinstate Tecfidera Patent
Benzinga via Yahoo Finance· 2 years agoThe U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 9 months agoViatris Inc (NASDAQ:VTRS), a pharmaceutical giant formed through the merger of Upjohn and Mylan,...
These Are 3 of the Nasdaq's Cheapest Dividend Stocks
Motley Fool· 1 year agoThe Nasdaq Composite is often associated with high-powered growth stocks. Three stocks that could potentially give you the best of both worlds are...
Viatris Insider Trading Scheme Busted
GuruFocus.com via Yahoo Finance· 2 years agoIf you have ever wondered why stocks seem to inexplicably rise hours and even days before big positive news and begin to weaken before big negative news,...
The Viatris Inc (VTRS) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoStrengths: Viatris Inc's expansive global presence and diversified portfolio position it as a leader...
Where Will Viatris Be in 5 Years?
Motley Fool· 10 months agoViatris (NASDAQ: VTRS) hasn't made for a particularly great investment since it formed nearly three years ago, through a merger of Mylan and Pfizer's...
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
Motley Fool· 10 months agoViatris (NASDAQ: VTRS) spun off from Pfizer and merged with Mylan back in 2020. It's a generic...
Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)
Insider Monkey via Yahoo Finance· 4 months agoGreenlight Capital, an investment management firm, released its fourth quarter 2023 investor letter,...
Is Viatris Inc. (VTRS) Modestly Overvalued?
GuruFocus.com via Yahoo Finance· 10 months agoWith a daily gain of 6.56% and a three-month gain of 22.89%, Viatris Inc. (NASDAQ:VTRS) has been catching the attention of investors. The company's...